Thanks H2R & totally agree with the fact that the external control groups not being followed long enough to know the true numbers of "lost-to-follow-up" patients & counting them is as "surviving". completely over estimates the control group survival cure. And as such, make the performance of DCVax treated patients ARTIFICIALLY poorer than the Excellent results reported!!!!
Also, I am happy that you you put a light on that critical observation, although as its very clear in the response to you, Dr. Bosch, thus all regulatory agencies and the oncology community are full aware off,
Adding more power to DCVax !!
Very long NWBO!!
Market Data 
Markets 
AI
